CinRx Pharma Announces First Study for the Treatment of Obesity
![](https://cinrx.com/wp-content/uploads/2022/09/cinfina-tile.jpg)
CinRx Pharma announced the first study participant has been dosed in CinFina’s Phase 1 multiple ascending dose (MAD) study of CIN-109.
CinRx Pharma announced the first study participant has been dosed in CinFina’s Phase 1 multiple ascending dose (MAD) study of CIN-109.